IRDiRC exists to make rare disease research efforts more efficient and collaborative, around the world.
- IRDiRC members are dedicated to the mission of progressing research for the 300 million people and families living with rare disease worldwide
- IRDiRC has brought together a global multi-stakeholder leadership consortium including research funders, patient advocacy groups, companies, scientists and experts to maximize the output of rare disease research and development
- IRDiRC is a catalyst connecting people and ideas, creating unique collaboration and developing or endorsing tools to stimulate impactful change in rare disease research
Shorten time to diagnosis
Shorten the time for patients to receive an accurate diagnosis
Promote therapeutics development
Develop solutions and discuss regulatory convergence to optimize and accelerate development of therapeutics and devices for rare disease globally
Optimize funding models
Identify funding gaps and propose relevant funding model in rare disease research
Promote rare disease research priorities globally
Conduct policy research and provide scientific credibility to enable the advancement of policies regarding rare disease research globally, including low-medium income countries